- Home
- BXC vs LAB Comparison
BXC vs LAB Comparison
Compare BXC & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BXC
- LAB
- Stock Information
- Founded
- BXC 2004
- LAB 1999
- Country
- BXC United States
- LAB United States
- Employees
- BXC N/A
- LAB N/A
- Industry
- BXC Wholesale Distributors
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- BXC Consumer Discretionary
- LAB Industrials
- Exchange
- BXC Nasdaq
- LAB Nasdaq
- Market Cap
- BXC 574.9M
- LAB 504.2M
- IPO Year
- BXC 2004
- LAB 2011
- Fundamental
- Price
- BXC $64.63
- LAB $1.21
- Analyst Decision
- BXC Strong Buy
- LAB Buy
- Analyst Count
- BXC 3
- LAB 2
- Target Price
- BXC $91.00
- LAB $2.50
- AVG Volume (30 Days)
- BXC 68.6K
- LAB 1.6M
- Earning Date
- BXC 11-04-2025
- LAB 11-04-2025
- Dividend Yield
- BXC N/A
- LAB N/A
- EPS Growth
- BXC N/A
- LAB N/A
- EPS
- BXC 3.42
- LAB N/A
- Revenue
- BXC $2,947,258,000.00
- LAB $172,271,000.00
- Revenue This Year
- BXC $1.54
- LAB N/A
- Revenue Next Year
- BXC $4.30
- LAB N/A
- P/E Ratio
- BXC $19.16
- LAB N/A
- Revenue Growth
- BXC N/A
- LAB 76.33
- 52 Week Low
- BXC $63.14
- LAB $0.92
- 52 Week High
- BXC $134.79
- LAB $2.32
- Technical
- Relative Strength Index (RSI)
- BXC 30.18
- LAB 42.73
- Support Level
- BXC $71.36
- LAB $1.12
- Resistance Level
- BXC $73.71
- LAB $1.25
- Average True Range (ATR)
- BXC 2.24
- LAB 0.09
- MACD
- BXC -0.56
- LAB -0.02
- Stochastic Oscillator
- BXC 9.82
- LAB 24.29
About BXC Bluelinx Holdings Inc.
BlueLinx Holdings Inc is engaged in the wholesale distribution of residential and commercial building products. Its business products are split into two categories: Structural products include items such as lumber, plywood, oriented strand board, rebar, and remesh and Specialty products include items such as engineered wood, siding, millwork, outdoor living, specialty lumber and panels, and industrial products. The company's operations are carried out throughout the United States.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.